Nutex Health Inc 2026年季度报告

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒As of April28, 2026, the registrant had 6,881,339 shares of common stock, $0.001 par value, outstanding. Includes the additional Table of Contents INTRODUCTORY NOTE Unless the context dictates otherwise, references in this Quarterly Report on Form 10-Q to the “Company,” “we,” “us,” “our,” “Nutex”and similar words are references to Nutex Health Inc., a Delaware corporation, and its consolidated subsidiaries and affiliated entities,as appropriate, including its consolidated variable interest entities (“VIEs”). CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, asamended (the “Securities Act”), and Section 21E of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”). Weintend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the This document contains certain forward-looking statements with respect to our financial condition, results of operations and business,plans, objectives and strategies. These forward-looking statements can be identified by the fact that they do not relate only to historicalor current facts. Forward-looking statements often use words such as “estimate,” “project,” “predict,” “will,” “would,” “should,”“could,” “may,” “might,” “anticipate,” “plan,” “intend,” “believe,” “expect,” “aim,” “goal,” “target,” “objective,” “commit,” These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions andassessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operatingenvironments, future developments and other factors we believe appropriate. By their nature, forward-looking statements involveknown and unknown risks and uncertainties because they relate to events and depend on circumstances that will occur in the future.The factors described in the context of such forward-looking statements in this document could cause our plans, actual results,performance or achievements, industry results and developments to differ materially from those expressed in or implied by such When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements describedunder, but not limited to, the heading “Item 1A. Risk Factors” included in this Quarterly Report, and in the Annual Report of Nutex NUTEX HEALTH INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Note 1 – Organization and Operations Nutex Health Inc. (“Nutex Health” or the “Company”), is a physician-led, healthcare services and operations company with 27hospital facilities in 12 states (hospital division), and a primary care-centric, risk-bearing population health management division. TheCompany's hospital division implements and operates different innovative health care models, including micro-hospitals, specialty The Company employs approximately 1,005 full-time employees, contracts over 280 doctors at our facilities and partners with over3,600 physicians within our networks as of March31, 2026. The Company's corporate headquarters is based in Houston, Texas and we Merger of Nutex Health Holdco LLC and Clinigence Holdings, Inc. On April 1, 2022, Nutex Health Holdco LLC merged withClinigence Holdings, Inc. (“Clinigence”), a publicly traded Delaware corporation, which was renamed Nutex Health Inc. after themerger (the “Merger”). Immediately prior to the Merger, holders of 84% of the aggregate equity interests in subsidiaries and affiliatesof Nutex Health Holdco LLC contributed these ownership interests to Nutex Health Holdco LLC in exchange for Nutex HealthHoldco LLC equity interests (“Contribution Agreements”). Immediately thereafter, in the Merger, each unit representing an equityinterest in Nutex Health Holdco LLC was converted into the right to receive shares of common stock of Clinigence (n/k/a NutexHealth Inc.). Refer toNote 11 – Stock-based Compensationfor discuss